India must ensure equitable, timely access to lenacapavir to tackle global HIV cases
New Delhi, Sep 29 (IANS) India must ensure equitable, timely global access to the World Health Organization (WHO) recommended lenacapavir -- the first twice-yearly injectable pre-exposure prophylaxis (PrEP) product -- to tackle the burden of HIV worldwide, according to an expert on Monday.